Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Name
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Accession Number
- DBCAT003359
- Description
Not Available
- Drugs
Drug Drug Description Zidovudine A dideoxynucleoside used in the treatment of HIV infection. Stavudine A dideoxynucleoside used in the treatment of HIV infection. Lamivudine A reverse transcriptase inhibitor used to treat HIV and hepatitis B infections. Emtricitabine A nucleoside reverse transcriptase inhibitor used for the treatment and prophylaxis of HIV. Didanosine A reverse transcriptase inhibitor used to treat HIV. Abacavir An antiviral nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals for the treatment of HIV. Tenofovir A nucleotide analog indicated in the treatment of HIV infections. Tenofovir disoproxil A nucleotide analog reverse transcriptase inhibitor used in the treatment of Hepatitis B infection and used in the management of HIV-1 infection. Tenofovir alafenamide A nucleoside analog reverse transcriptase inhibitor used for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease. Abacavir hydroxyacetate Prurisol is under investigation for the treatment of Chronic Stable Plaque Psoriasis. Prurisol has been investigated for the treatment of Plaque Psoriasis. - Drugs & Drug Targets